|
|
Volumn 3, Issue 9, 2012, Pages 913-914
|
|
Bruton's tyrosine kinase: Oncotarget in myeloma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B LYMPHOCYTE RECEPTOR;
BRUTON TYROSINE KINASE;
CD19 ANTIGEN;
IBRUTINIB;
MYELOID DIFFERENTIATION FACTOR 88;
BONE ATROPHY;
BONE DENSITY;
BONE DISEASE;
CANCER RESISTANCE;
DRUG CYTOTOXICITY;
DRUG EFFICACY;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG RESISTANCE;
DRUG SAFETY;
EDITORIAL;
GENE EXPRESSION PROFILING;
GENE MUTATION;
HUMAN;
MULTIPLE MYELOMA;
NONHUMAN;
OSSIFICATION;
OSTEOCLAST;
PROTEIN EXPRESSION;
PROTEIN TARGETING;
SIGNAL TRANSDUCTION;
TUMOR MICROENVIRONMENT;
WALDENSTROEM MACROGLOBULINEMIA;
|
|
EID: 84868622990
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.655 Document Type: Editorial |
|
Times cited : (25)
|
|
References (8)
|
